drugset / Trial / NCT00945191
Combination Chemotherapy With CS-1008 to Treat Ovarian Cancer
NaSingle-groupOpen-labelTreatment
Summary
This trial assessed the effect of treatment with CS-1008 in combination with paclitaxel/carboplatin on response in patients with locally advanced or metastatic ovarian cancer.
Timeline
- Start
- 2009-10-06
- Primary completion
- 2011-08-23
- Completion
- 2011-08-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | tigatuzumab | Monoclonal antibody | 8 mg/kg | Intravenous |
| Background | Carboplatin | Small molecule | 6 unknown | Intravenous |
| Background | Paclitaxel | Small molecule | 175 mg/m2 | Intravenous |